Agenda

We would like to thank our exhibitors for sponsoring this meeting, which includes pharmaceutical companies. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

If you are interested in speaking at this event, please contact Pippa Baynham, Senior Conference Producer.

If you are interested in sponsoring a talk on the Agenda, or exhibiting at the event, please contact Edward Burkle, Executive Director

 

Wednesday, July 2, 2025
9:20 AM - 10:15 AM
Chair’s opening remarks followed by: FIND-AF: The power of AI in diagnosis
  • What is FIND-AF?
  • Why was it developed?
  • How does it work and what will the impact be?
Helena Beer, Editor, Hospital Healthcare Europe, Hospital Pharmacy Europe
Chris Gale, Cardiovascular Medicine, Honorary Consultant Cardiologist, Co-Director, Leeds Insitute of Data Analytics, University of Leeds
 
 
10:25 AM - 11:10 AM
Approaches for advanced therapies in cardiovascular disease treatments
  • What advanced therapy approaches are being used and why
  • How they are being delivered to the patient
  • What the benefits will there be to patient care
  • How can healthcare systems implement testing of these approaches
Andrew Baker, Head of Centre for Cardiovascular Science, Gustav Born Chair of Vascular Biology, The University of Edinburgh
 
 
11:20 AM - 12:05 PM
Sponsored session to be confirmed
 
 
 
 
12:15 PM - 1:00 PM
Remote monitoring of cardiac arrhythmias using wearable digital technology: Paradigm shift or pipe dream
  • Overview of the current digital health landscape with regards to wearables and remote monitoring in cardiovascular medicine
  • Landmark clinical trials
  • Future direction of remote monitoring of cardiac arrhythmias
Gamith Adasuriya, Cardiology Specialist Registrar and Operations Lead, Mara Health, Guy’s and St Thomas’ NHS Foundation Trust
 
 
1:10 PM - 1:55 PM
Severe aortic stenosis 8-week fast track pathway: An approach to improve patient outcome
  • The impact of delays in treatment of severe aortic valve disease.
  • Role of the heart team in streamlining the pathway.
  • How virtual technology can improve patient care in managing aortic valve disease.
Kerry Pena, Lead Cardiac Valve Nurse Specialist, Leeds Teaching Hospitals Trust
 
 
2:05 PM - 2:50 PM
Session to be confirmed
 
 
 
 
3:00 PM - 3:45 PM
Bridging cardiology and oncology: Cardiovascular disease in cancer patients
  • Impact of cancer treatments on cardiovascular health
  • Tools and guidelines for cardiovascular risk assessment in cancer patients
  • Addressing challenges and barriers in implementing cardio-oncology care
Dr. Alexander Lyon, Consultant Cardiologist, Clinical Lead for Cardio-Oncology Service, Director of the Cardio-Oncology, Centre of Excellence - Royal Brompton Hospital
 
 

Speakers